VEGFA and diabetic cardiomyopathy: More recently, Shida et al. investigated the effects of fluvastatin on diabetic cardiomyopathy and observed that the cardiac function was significantly improved through a reduction in myocardial oxidative stress and increase in VEGF levels [64].